What Is Participant Payment Actually Supposed to Compensate For?

What Exactly Are You Paying a Research Participant For?

"Participants will receive $50."

That sentence tells an ethics committee the amount, but it leaves a more fundamental question unanswered: what is the $50 supposed to compensate for?

Researchers often begin payment planning with a number. A more defensible approach begins with the participant's experience. How much time will participation require? What effort, inconvenience, discomfort, or disruption does it involve? Will the participant incur expenses or give up other opportunities?

Once those questions are clear, the amount has something to be based on rather than becoming an arbitrary figure inherited from the previous study in the department.

Compensation Usually Recognizes Contribution and Burden

Start With What Participation Actually Requires

Time Is the Most Obvious Contribution, but Not the Only One

Research consumes participant time. A ten-minute questionnaire and a six-hour laboratory visit are not equivalent simply because both produce one completed dataset.

SACHRP explicitly identifies time as a legitimate basis for compensation. CIOMS similarly states that research participants should be reasonably compensated for time spent and inconvenience and indicates that compensation should be proportional to time spent for research purposes and travel to the research site.

Time provides a relatively observable basis for payment. Researchers can estimate interview duration, study visits, procedures, diary completion, travel associated with participation, and other required activities.

But paying strictly by the minute can also oversimplify what participation demands.

Effort Can Matter Even When the Clock Looks the Same

Two studies can each require one hour while imposing very different demands.

One participant might complete a straightforward questionnaire at home. Another might perform repetitive cognitive tasks, maintain sustained concentration, provide multiple specimens, complete a difficult interview, or follow complicated study procedures. The elapsed time is identical, but the experience is not.

SACHRP describes compensation as recognizing time and effort as well as research-related burdens and inconvenience. That formulation allows researchers to consider what participants are actually being asked to do, rather than reducing every contribution to duration alone.

Inconvenience Is Real Even When It Has No Receipt

Some burdens are neither direct expenses nor easily measured labor.

A participant may have to wake earlier than usual, fast before a procedure, rearrange childcare, repeatedly travel across town, attend appointments during working hours, wait between procedures, wear a monitoring device, or alter an ordinary routine.

These experiences can reasonably form part of the justification for compensation. CIOMS explicitly identifies inconvenience as a basis for reasonable compensation, while SACHRP likewise treats burdens and inconvenience as relevant to compensation.

The first may be addressed through reimbursement. The second may help justify compensation. Keeping the concepts separate prevents researchers from assuming that refunding a bus fare fully recognizes everything the participant contributed.

Opportunity Cost Helps Explain Why Time May Deserve Compensation

Research participation occupies time that could have been spent elsewhere. Economists describe the value of the forgone alternative as an opportunity cost.

SACHRP uses this concept when discussing participant compensation. Someone attending a research visit may forgo paid work or another valuable activity. Compensation can help make research participation more comparable with other ways the person might have spent that time.

That does not necessarily mean researchers should calculate each participant's actual salary and replace every peso or dollar of forgone earnings. SACHRP specifically identifies an equity problem with individualized compensation based on earning capacity: participants completing the same procedures could receive substantially different amounts merely because one earns more outside the study.

Its recommended approach favors equitable compensation for comparable participation rather than attempting to reproduce each person's individual market wage.

Expenses Are Usually Better Understood as Reimbursement

Transportation, parking, lodging, childcare, and other reasonable study-related expenses can create a direct financial burden. These are conceptually different from payment recognizing time or inconvenience.

SACHRP therefore separates reimbursement from compensation. FDA likewise distinguishes reimbursement for reasonable travel and lodging expenses from payment for participation when discussing undue influence.

This distinction is useful even if your institution uses compensation as a broad umbrella term. Separating reimbursement from compensation and incentives makes the ethical purpose of each amount easier to defend.

Should Compensation Include Discomfort?

This question is more complicated because discomfort can overlap with inconvenience, burden, and risk.

FDA explicitly identifies time, inconvenience, and discomfort among the considerations that IRBs may confront when evaluating payment. SACHRP refers more broadly to research-related burdens and gives examples of participants undertaking more extensive or uncomfortable study visits.

Reasonable differences in compensation may therefore reflect differences in what participants are required to undergo. But discomfort should not become a backdoor method of pricing research risk without further ethical analysis.

Risk Requires Special Care

Risk is where an apparently simple payment formula becomes ethically difficult.

Researchers should distinguish two questions. First, is the research risk itself ethically acceptable? Second, if the study is acceptable, may payment reflect some aspect of the participant's experience of that risk?

FDA states that payment for research participation is not a benefit to be counted when weighing study risks and benefits. OHRP likewise maintains that remuneration should not be used by an IRB as a way of offsetting research risks when deciding whether a study is approvable.

At the same time, OHRP has clarified that remuneration may include compensation associated with risks and that such compensation may be an acceptable motivation for a participant. CIOMS takes a more restrictive approach in its 2016 health-research guidance, stating that compensation is intended for inconvenience and time rather than for the risk participants agree to undertake.

The narrower questions of whether payment should reflect time, inconvenience, risk, or all three and whether riskier research should pay more therefore require careful treatment in their own right.

Compensation Is Not the Price of the Participant's Data

Another tempting interpretation is that researchers are buying answers, specimens, or data from participants. That framing is usually misleading.

Participant payment does not ordinarily mean that each completed survey response or blood sample has been assigned a purchase price. The participant remains a research participant with applicable rights and protections. Payment may recognize the person's contribution to producing socially valuable knowledge, but it does not transform informed consent into a sale of ethical protections.

This distinction becomes particularly important when researchers encounter incomplete, unexpected, or apparently low-quality data. Whether payment can be refused because survey responses appear careless or unusable is not answered merely by saying that the researcher did not receive the data they hoped to obtain.

Compensation Is Not Necessarily a Precise Economic Replacement

The word compensation can sound as though the goal is to calculate every cost and make the participant perfectly whole. In practice, ethical guidance does not require such precision in every case.

SACHRP notes that actual opportunity costs differ among individuals but favors equity rather than individualized payment based on earning capacity. CIOMS recommends reasonable compensation and suggests using the minimum hourly wage in the relevant region or country as a reference value for time in health-related research.

These are frameworks for justification, not a universal formula applicable to every discipline and jurisdiction.

Breaking Down What a Participant Actually Contributes

This approach does not magically produce one ethically correct number. It does something more useful: it makes the reasoning visible. An ethics committee can evaluate what the payment is meant to recognize and whether the proposed amount and conditions are defensible in context.

Common Mistakes When Justifying Participant Compensation

Build the Payment Rationale Before Choosing the Number

A defensible participant-payment plan can begin with an inventory of what participation requires. This does not mean assigning a separate monetary price to every inconvenience. It means understanding the burdens before deciding what payment is reasonable.

Only after this analysis does the question of how much participant payment is too much become meaningful. A number cannot be evaluated sensibly without knowing what it is intended to do.

Before Setting Participant Compensation

Frequently Asked Questions About What Participant Payment Covers

Compensate the Contribution, Not Simply the Completed Dataset

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.